![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00530699 |
The purpose of this study is to assess safety and tolerability of multiple ascending doses of AZD1152 and to assess effect of AZD1152 on the rate of complete remission in patients with relapsed acute myeloid leukaemia
Condition | Intervention | Phase |
---|---|---|
Acute Myeloid Leukaemia |
Drug: AZD1152 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | A Phase I, Open Label, Multi-Centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD1152 in Japanese Patients With Acute Myeloid Leukaemia. |
Estimated Enrollment: | 30 |
Study Start Date: | November 2007 |
Estimated Study Completion Date: | June 2009 |
Ages Eligible for Study: | 20 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZeneca Clinical Information Center | 1/800-236-9933 | information.center@astrazeneca.com |
Contact: AstraZeneca Japan Pharmaceuticals | +81 (0)6 6453 7500 |
Japan | |
Research Site | Recruiting |
FUKUOKA, Japan | |
Japan, AICHI | |
Research Site | Recruiting |
NAGOYA, AICHI, Japan | |
Japan, FUKUI | |
Research Site | Recruiting |
YOSHIDA-GUN, FUKUI, Japan | |
Japan, KANAGAWA | |
Research Site | Recruiting |
ISEHARA, KANAGAWA, Japan | |
Research Site | Recruiting |
YOKOHAMA, KANAGAWA, Japan | |
Japan, Mie | |
Research Site | Recruiting |
Tsu, Mie, Japan | |
Japan, Tokyo | |
Research Site | Recruiting |
Chuo, Tokyo, Japan |
Study Director: | Paul Stockman | AstraZeneca |
Responsible Party: | Japan Pharmaceuticals ( AstraZeneca ) |
Study ID Numbers: | D1531C00008 |
Study First Received: | September 13, 2007 |
Last Updated: | August 27, 2008 |
ClinicalTrials.gov Identifier: | NCT00530699 |
Health Authority: | Japan: Pharmaceuticals and Medical Devices Agency |
Acute Myeloid Leukaemia Phase 1 AZD1152 |
Leukemia Acute myelogenous leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Acute myelocytic leukemia |
Neoplasms Neoplasms by Histologic Type |